FDA Inspection
Gilead Sciences, Inc.Gilead Sciences, Inc. – FDA Inspection, Dec 17, 2021
Record Details
This FDA Inspection record concerns Gilead Sciences, Inc., with an inspection on December 17, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Gilead Sciences, Inc.
- Inspection Date
- December 17, 2021
- Product Type
- Drugs
View Company Profile
ID · f3390bd4-1e60-4b26-8250-0f3b5623886a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1159086
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gilead Sciences, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2026 | VAI | Los Angeles District Office | Drug Quality Assurance |
| February 12, 2024 | VAI | Los Angeles District Office | New Drug Evaluation |
| May 14, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gilead Sciences, Inc.
- FDA Inspection 1304734 - 2026-02-18
- FDA Inspection 1229435 - 2024-02-12
- FDA Inspection 1093610 - 2019-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.